Evolution Advisers’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$129K Buy
509
+106
+26% +$24.7K 0.05% 69
2026
Q1
$98K Hold
403
0.04% 64
2025
Q4
$83K Hold
403
0.04% 67
2025
Q3
$75K Buy
403
+1
+0.2% +$171 0.03% 76
2025
Q2
$61K Sell
402
-49
-11% -$7.53K 0.03% 82
2025
Q1
$74K Buy
451
+39
+9% +$6.1K 0.04% 73
2024
Q4
$59K Hold
412
0.03% 83
2024
Q3
$66K Buy
412
+1
+0.2% +$159 0.04% 78
2024
Q2
$60K Buy
411
+10
+2% +$1.49K 0.03% 82
2024
Q1
$64K Buy
401
+1
+0.3% +$159 0.04% 78
2023
Q4
$64K Buy
400
+101
+34% +$15.5K 0.04% 75
2023
Q3
$46K Sell
299
-5
-2% -$825 0.03% 66
2023
Q2
$50K Buy
304
+1
+0.3% +$161 0.04% 66
2023
Q1
$47K Buy
303
+7
+2% +$1.13K 0.03% 62
2022
Q4
$52K Hold
296
0.04% 61
2022
Q3
$48K Buy
296
+1
+0.3% +$169 0.04% 60
2022
Q2
$53K Buy
295
+1
+0.3% +$178 0.04% 59
2022
Q1
$52K Buy
294
+200
+213% +$34K 0.04% 62
2021
Q4
$16K Buy
+94
New +$15.4K 0.01% 84

Other funds holding JNJ

Evolution Advisers's JNJ Position: Q2 2026 in Review

Evolution Advisers increased its Johnson & Johnson (JNJ) stake by 26% in Q2 2026, buying an estimated $24.7K and bringing the position to 509 shares worth $129K. The position accounts for 0.05% of the portfolio, ranked #69.

Evolution Advisers first reported a position in JNJ in Q4 2021 and has held it in 19 quarters since. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Evolution Advisers held 509 shares of Johnson & Johnson worth $129K as of Q2 2026.
  • Evolution Advisers bought 106 Johnson & Johnson shares in Q2 2026, an estimated $24.7K.
  • Johnson & Johnson made up 0.05% of Evolution Advisers's portfolio in Q2 2026, its #69 holding.
  • Evolution Advisers first reported a position in Johnson & Johnson in Q4 2021 and has held it in 19 quarters since.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Evolution Advisers's 13F filing for Q2 2026, filed 31 Jul 2026.